Summit Therapeutics Inc

NAS:SMMTHealthcareNASDAQ:NBINASDAQ:NQUSMG

$15.57+6.43%At closeAt close · Tue 20 Oct · ≈ AED 57.18 · Market cap $12.42B · Next earnings Wed 11 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	100.0%	100.0%	100.0%	—	—	—	—	—
Operating margin	−11,392.7%	−4,764.3%	−10,225.4%	—	—	—	—	—
Net margin	−6,127.6%	−4,897.8%	−11,174.8%	—	—	—	—	—
EBITDA margin	−5,904.9%	−4,807.8%	−8,845.1%	—	—	—	—	—
Return on equity	−66.0%	−106.1%	−63.1%	−784.6%	−56.9%	−220.8%	−163.9%	+56.9 pts
Return on assets	−51.2%	−78.0%	−12.0%	−300.3%	−50.8%	−193.6%	−143.7%	+49.9 pts
Return on capital employed	−118.1%	−98.0%	−11.7%	−331.1%	−57.4%	−217.4%	—	—
Debt / equity	0.0×	0.0×	4.1×	1.4×	0.0×	0.0×	0.0×	+0.0%
Debt / assets	0.5%	2.5%	78.1%	52.3%	1.7%	2.8%	—	—
Interest coverage	−281.0×	−306.0×	−13.5×	−29.1×	−20.8×	0.0×	—	—
Current ratio	4.4×	3.8×	16.9×	9.3×	10.2×	9.9×	9.9×	+0.0%
Quick ratio	4.4×	3.8×	16.9×	9.3×	10.2×	9.9×	—	—
Cash ratio	3.3×	2.8×	9.0×	3.5×	2.5×	3.1×	3.1×	+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Receivables turnover	0.1×	0.1×	0.1×	0.0×	0.0×	—	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.